Your browser doesn't support javascript.
loading
Effects of Botulinum Toxin-A and Goal-Directed Physiotherapy in Children with Cerebral Palsy GMFCS Levels I & II.
Löwing, Kristina; Thews, Karin; Haglund-Åkerlind, Yvonne; Gutierrez-Farewik, Elena M.
Afiliação
  • Löwing K; a Department of Women's and Children's Health , Karolinska Institutet , Stockholm , Sweden.
  • Thews K; a Department of Women's and Children's Health , Karolinska Institutet , Stockholm , Sweden.
  • Haglund-Åkerlind Y; a Department of Women's and Children's Health , Karolinska Institutet , Stockholm , Sweden.
  • Gutierrez-Farewik EM; a Department of Women's and Children's Health , Karolinska Institutet , Stockholm , Sweden.
Phys Occup Ther Pediatr ; 37(3): 268-282, 2017 Aug.
Article em En | MEDLINE | ID: mdl-27058177
AIMS: To evaluate short and long-term effects of botulinum toxin-A combined with goal-directed physiotherapy in children with cerebral palsy (CP). METHOD: A consecutive selection of 40 children, ages 4-12 years, diagnosed with unilateral or bilateral CP, and classified in GMFCS levels I-II. During the 24 months, 9 children received one BoNT-A injection, 10 children two injections, 11 children three injections, and 10 children received four injections. 3D gait analysis, goal-attainment scaling, and body function assessments were performed before and at 3, 12, and 24 months after initial injections. RESULTS: A significant but clinically small long-term improvement in gait was observed. Plantarflexor spasticity was reduced after three months and remained stable, while passive ankle dorsiflexion increased after 3 months but decreased slightly after 12 months. Goal-attainment gradually increased, reached the highest levels at 12 months, and levels were maintained at 24 months. CONCLUSION: The treatments' positive effect on spasticity reduction was identified, but did not relate to improvement in gait or goal-attainment. No long-term positive change in passive ankle dorsiflexion was observed. Goal attainment was achieved in all except four children. The clinical significance of the improved gait is unclear. Further studies are recommended to identify predictors for positive treatment outcome.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Paralisia Cerebral / Toxinas Botulínicas Tipo A / Marcha / Espasticidade Muscular Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Phys Occup Ther Pediatr Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Paralisia Cerebral / Toxinas Botulínicas Tipo A / Marcha / Espasticidade Muscular Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Phys Occup Ther Pediatr Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Suécia